In 2016 WHO categorization, codeletion of chromosomal arms 1p/19q (1p/19q codeletion) and isocitrate dehydrogenase 1 or 2 (IDH1 or IDH2) were included in the diagnostic typing for glioma classification [2, 56]. Here, IDH2 is linked to central nervous system cancer.